{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T12:00:24Z","timestamp":1780228824734,"version":"3.54.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prp.2026.156522","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:23:11Z","timestamp":1778811791000},"page":"156522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mesothelioma in situ-spectrum pleural lesions: Diagnostic challenges and longitudinal follow-up in a case series"],"prefix":"10.1016","volume":"285","author":[{"given":"Federica","family":"Pezzuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Giraudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Biondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Maria","family":"Pontoriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fortarezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dell\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156522_bib1","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"International Agency for Research on Cancer (IARC)","year":"2021"},{"key":"10.1016\/j.prp.2026.156522_bib2","article-title":"Bilateral pleural mesothelioma in situ and peritoneal mesothelioma in situ associated with BAP1 germline mutation: a case report","volume":"3","author":"MacLean","year":"2022","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.prp.2026.156522_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/dc.25272","article-title":"Investigation of MTAP and BAP1 staining loss and P16\/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma","volume":"52","author":"\u015eeker","year":"2024","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2026.156522_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CEJ.0000000000000883","article-title":"Pleural mesothelioma in situ: a comprehensive review","volume":"33","author":"Danuzzo","year":"2024","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.prp.2026.156522_bib5","first-page":"10001","article-title":"Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology","volume":"27","author":"Aydogdu","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2026.156522_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jasc.2022.12.001","article-title":"The cytologic diagnosis of mesothelioma: are we there yet?","volume":"12","author":"Michael","year":"2023","journal-title":"J. Am. Soc. Cytopathol."},{"key":"10.1016\/j.prp.2026.156522_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/dc.25129","article-title":"The cytological features of effusions with mesothelioma in situ: a report of 9 cases","volume":"51","author":"Michael","year":"2023","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2026.156522_bib8","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220128","article-title":"Mesotheliomas and Benign mesothelial tumors: update on pathologic and imaging findings","volume":"43","author":"Bonde","year":"2023","journal-title":"Radiographics"},{"key":"10.1016\/j.prp.2026.156522_bib9","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/OP-25-00035","article-title":"Treatment of pleural mesothelioma: ASCO guideline clinical insights","volume":"21","author":"Kindler","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.prp.2026.156522_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jtho.2022.11.018","article-title":"Considerations for imaging of malignant pleural mesothelioma: a consensus statement from the international mesothelioma interest group","volume":"18","author":"Katz","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2026.156522_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2606","volume":"33","author":"Popat","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2026.156522_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/arpa.2023-0304-RA","article-title":"Guidelines for pathologic diagnosis of mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"148","author":"Husain","year":"2024","journal-title":"Arch Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2026.156522_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","article-title":"The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification","volume":"17","author":"Sauter","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2026.156522_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/his.15007","article-title":"New developments in mesothelial pathology","volume":"84","author":"Churg","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2026.156522_bib15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41379-022-01082-y","article-title":"Well differentiated papillary mesothelial tumor: a new name and new problems","volume":"35","author":"Churg","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156522_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.pathol.2024.02.016","article-title":"The significance of BAP1 and MTAP\/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature","volume":"56","author":"Hassan","year":"2024","journal-title":"Pathology"},{"key":"10.1016\/j.prp.2026.156522_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100420","article-title":"Comparison of immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma","volume":"37","author":"Febres-Aldana","year":"2024","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156522_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156522_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/PAS.0000000000002033","article-title":"Mesothelioma in situ mimicking well-differentiated papillary mesothelial tumor","volume":"47","author":"Galateau-Salle","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2026.156522_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pathol.2021.06.124","article-title":"Progression of mesothelioma in situ to invasive disease 4 years and 10 months after initial diagnosis","volume":"54","author":"Klebe","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.prp.2026.156522_bib21","article-title":"Individualized cell-free DNA monitoring with chromosomal junctions for mesothelioma","volume":"5","author":"Parikh","year":"2024","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.prp.2026.156522_bib22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jtho.2020.03.014","article-title":"Malignant mesothelioma in situ: clinical and pathologic implications","volume":"15","author":"Churg","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2026.156522_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pathol.2020.12.005","article-title":"The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis","volume":"53","author":"Klebe","year":"2021","journal-title":"Pathology"},{"key":"10.1016\/j.prp.2026.156522_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in situ: morphologic features and clinical outcome","volume":"33","author":"Churg","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156522_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J. Transl. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T11:03:38Z","timestamp":1780225418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0344033826001755"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156522","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelioma in situ-spectrum pleural lesions: Diagnostic challenges and longitudinal follow-up in a case series","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156522"}}